Position in MRK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$15,207,332
+$1,263,075 QoQ
Shares Held
118,345
+2.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#590
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $46,475,498 across 14 Drug Manufacturers - General names. MRK ranks #1 (32.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
118,345 | $15,207,332 | |
| 2 | JNJ |
Johnson & Johnson
|
58,033 | $14,738,640 | |
| 3 | AMGN |
Amgen Inc
|
28,143 | $10,191,142 | |
| 4 | LLY |
ELI LILLY & Co
|
1,816 | $2,178,165 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,971 | $1,638,755 | |
| 6 | ABBV |
AbbVie Inc.
|
5,799 | $1,459,260 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,952 | $342,954 | |
| 8 | NVO |
Novo Nordisk A S
|
4,826 | $231,358 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,207,332 | 118,345 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $13,944,257 | 115,922 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $11,999,324 | 113,997 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $9,535,287 | 113,610 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $9,265,598 | 117,049 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $10,848,302 | 120,859 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $12,138,548 | 122,020 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $14,006,830 | 123,343 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $15,058,660 | 121,637 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $16,008,174 | 121,320 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $13,080,110 | 119,979 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $12,101,154 | 117,544 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $13,410,625 | 116,220 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,865,144 | 111,525 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $12,155,792 | 109,561 | Shares | Sole | 2023-02-16 | |
| 2022-06-30 | $9,480,677 | 103,989 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,290,742 | 101,045 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $7,421,587 | 96,837 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,172,178 | 95,489 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,745,069 | 86,731 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,538,777 | 84,820 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,509,150 | 79,574 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,059,334 | 73,048 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,429,618 | 57,282 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,760,056 | 48,870 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||